Matching Items (85)
161961-Thumbnail Image.png
Description
Organic materials have emerged as an attractive component of electronics over the past few decades, particularly in the development of efficient and stable organic light-emitting diodes (OLEDs) and organic neuromorphic devices. The electrical, chemical, physical, and optical studies of organic materials and their corresponding devices have been conducted for efficient

Organic materials have emerged as an attractive component of electronics over the past few decades, particularly in the development of efficient and stable organic light-emitting diodes (OLEDs) and organic neuromorphic devices. The electrical, chemical, physical, and optical studies of organic materials and their corresponding devices have been conducted for efficient and stable electronics. The development of efficient and stable deep blue OLED devices remains a challenge that has obstructed the progress of large-scale OLED commercialization. One approach was taken to achieve a deep blue emitter through a color tuning strategy. A new complex, PtNONS56-dtb, was designed and synthesized by controlling the energy gap between T1 and T2 energy states to achieve narrowed and blueshifted emission spectra. This emitter material showed an emission spectrum at 460 nm with a FWHM of 59 nm at room temperature in PMMA, and the PtNONS56-dtb-based device exhibited a peak EQE of 8.5% with CIE coordinates of (0.14, 0.27). A newly developed host and electron blocking materials were demonstrated to achieve efficient and stable OLED devices. The indolocarbazole-based materials were designed to have good hole mobility and high triplet energy. BCN34 as an electron blocking material achieved the estimated LT80 of 12509 h at 1000 cd m-2 with a peak EQE of 30.3% in devices employing Pd3O3 emitter. Additionally, a device with bi-layer emissive layer structure, using BCN34 and CBP as host materials doped with PtN3N emitter, achieved a peak EQE of 16.5% with the LT97 of 351 h at 1000 cd m-2. A new neuromorphic device using Ru(bpy)3(PF6)2 as an active layer was designed to emulate the short-term characteristics of a biological synapse. This memristive device showed a similar operational mechanism with biological synapse through the movement of ions and electronic charges. Furthermore, the performance of the device showed tunability by adding salt. Ultimately, the device with 2% LiClO4 salt shows similar timescales to short-term plasticity characteristics of biological synapses.
ContributorsShin, Samuel (Author) / Li, Jian (Thesis advisor) / Adams, James (Committee member) / Alford, Terry (Committee member) / Arizona State University (Publisher)
Created2021
168283-Thumbnail Image.png
Description
Over the past three decades, significant progress in the development of organic light-emitting diodes (OLEDs) has been achieved, enabling OLEDs to become a main component in state-of-the-art displays and next generation solid-state lighting. As this technology advances, it is highly desirable to further improve the device efficiency and operational stability

Over the past three decades, significant progress in the development of organic light-emitting diodes (OLEDs) has been achieved, enabling OLEDs to become a main component in state-of-the-art displays and next generation solid-state lighting. As this technology advances, it is highly desirable to further improve the device efficiency and operational stability to drive the success of OLEDs in future display and lighting applications. This dissertation aims at developing novel organic emitting materials covering visible and near-infrared (NIR) emissions for efficient and table OLEDs. Firstly, a series of tetradentate Pd(II) complexes, which have attractive phosphorescent aggregate emission performance especially at high brightness level in device settings, have been developed. The luminescent lifetime of Pd(II) complex aggregates was demonstrated to be shorter than 1 μs with a close-to-unity photoluminescence quantum yield. Moreover, a systematic study regarding structure-property relationship was conducted on four tetradentate Pd(II) complexes, i.e., Pd3O3, Pd3O8-P, Pd3O8-Py2, and Pd3O8-Py5, featuring aggregate emission. As a result, an extremely efficient and stable OLED device utilizing Pd3O8-Py5 was achieved. It demonstrated a peak external quantum efficiency (EQE) of 37.3% with a reduced efficiency roll-off retaining a high EQE of 32.5% at 10000 cd m-2, and an estimated LT95 lifetime (time to 95% of the initial luminance) of 48246 h at 1000 cd m-2. Secondly, there is an increasing demand for NIR OLEDs with emission spectra beyond 900 nm to expand their applications in biometric authentication, night vision display, and telecommunication, etc. A stable and efficient NIR Pt(II) porphyrin complex named PtTPTNP-F8 was developed, and exhibited an electroluminescent spectrum at 920 nm. By carefully choosing the host materials, an PtTPTNP-F8 based NIR OLED achieved a EQE of 1.9%. Furthermore, an PtTPTNP-F8 OLED fabricated in a stable device structure demonstrated extraordinary operational stability with LT99 of >1000 h at 20 mA cm-2. Lastly, a series of imidazole-based blue Pt(II) complexes were developed and studied. Results indicated that structural modification of ligand molecules effectively tuned the emission spectral wavelength and bandwidth. Two blue complexes, i.e., Pt2O2 P2M and Pt2O2-PPy5-M, emitting at 472 and 476 nm respectively, exhibited narrow-band emission spectra with a full width at half maximum of 16 nm.
ContributorsCao, Linyu (Author) / Li, Jian (Thesis advisor) / Adams, James (Committee member) / Alford, Terry (Committee member) / Arizona State University (Publisher)
Created2021
165870-Thumbnail Image.png
Description

The purpose of this project was to develop a new questionnaire that was comprehensive and included symptoms of autism and related disorders. 28 parents of children with autism and two adults with autism were interviewed and asked to fill out the questionnaire and rate their child’s symptoms based on the

The purpose of this project was to develop a new questionnaire that was comprehensive and included symptoms of autism and related disorders. 28 parents of children with autism and two adults with autism were interviewed and asked to fill out the questionnaire and rate their child’s symptoms based on the available scale. From their responses, we were able to edit and improve the questionnaire to make it clearer and more concise. We added new symptoms and improved the descriptions of the symptoms listed. The new version of the questionnaire will be edited after interviewing the same 30 people again. After, it will need to be validated by a large study of around 300 people. The questionnaire will be used in an app format and help parents rate their child’s symptoms during clinical studies of medical treatments.

ContributorsFoote, Sophia (Author) / Adams, James (Thesis director) / Duane, Drake (Committee member) / Barrett, The Honors College (Contributor) / Watts College of Public Service & Community Solut (Contributor) / School of International Letters and Cultures (Contributor) / School of Human Evolution & Social Change (Contributor)
Created2022-05
Description
For my thesis I investigated an abnormal gut-derived metabolite of interest identified as 3-(3-hydroxyphenyl)-3-hydroxypropionic acid (HPHPA) that may serve as a potential biomarker for autism, and help us get a better understanding of the underlying mechanisms of this disorder. Currently a laboratory test for autism does not exist, posing severe

For my thesis I investigated an abnormal gut-derived metabolite of interest identified as 3-(3-hydroxyphenyl)-3-hydroxypropionic acid (HPHPA) that may serve as a potential biomarker for autism, and help us get a better understanding of the underlying mechanisms of this disorder. Currently a laboratory test for autism does not exist, posing severe consequences on individuals with autism. In order to gather research on my metabolite of interest and its connection to autism as well as disorders correlated with autism, I analyzed different pieces of scientific literature investigating HPHPA and compiled this data into a literature review.
ContributorsNawaz, Umar (Author) / Adams, James (Thesis director) / Krajmalnik-Brown, Rosa (Committee member) / Flynn, Christina (Committee member) / Barrett, The Honors College (Contributor) / School of Life Sciences (Contributor)
Created2024-05
Description
Autism Spectrum Disorder (ASD) is an intricate neurodevelopmental disorder characterized by impaired social functioning and communication, repetitive behavioral patterns, and specialized interests (Olesova et al., 2020; Osredkar et al., 2023). Despite the efforts of modern science, the biological origin of ASD is unknown, and no known biomarker for ASD currently

Autism Spectrum Disorder (ASD) is an intricate neurodevelopmental disorder characterized by impaired social functioning and communication, repetitive behavioral patterns, and specialized interests (Olesova et al., 2020; Osredkar et al., 2023). Despite the efforts of modern science, the biological origin of ASD is unknown, and no known biomarker for ASD currently exists (Olesova et al., 2020; Osredkar et al., 2023). Indoxyl sulfate has been identified as a toxin associated with ASD and its related symptomology in addition to a number of other conditions, including chronic kidney disease, acute kidney injury, heart failure, Parkinson’s disease, and various mood disorders (Cao et al., 2015; Cassani et al., 2015; Karbowska et al., 2020; Zhao et al., 2013). This article will review what is currently known about indoxyl sulfate in relation to ASD and its comorbidities in an attempt to determine the validity of indoxyl sulfate as a potential biomarker for ASD. Articles for the purposes of this review were collected via Google Scholar, PubMed, and the ASU Library using key words such as “indoxyl sulfate,” “Autism,” and “indican,” and chosen based on relevancy. Through this review, indoxyl sulfate was identified as a potential physiological biomarker for a subset of ASD, with additional research required to verify the findings presented. The identification of a biomarker for ASD could change the current methods of testing for ASD, greatly improving our understanding and treatment of the disorder.
ContributorsHill, Zoë (Author) / Adams, James (Thesis director) / Flynn, Christina (Committee member) / Barrett, The Honors College (Contributor) / College of Health Solutions (Contributor) / Edson College of Nursing and Health Innovation (Contributor)
Created2024-05
DescriptionThis paper studies the potential correlation between succinate levels and ASD. A part of the electron transport chain and the Krebs cycle, succinate has been seen to be potentially relevant to the neurodevelopmental aspects of ASD.
ContributorsKale, Anushka (Author) / Adams, James (Thesis director) / Flynn, Christina (Committee member) / Barrett, The Honors College (Contributor) / School of Life Sciences (Contributor) / School of Human Evolution & Social Change (Contributor)
Created2024-05
Description
The purpose of this thesis is to analyze in-depth the current research on Autism Spectrum Disorder (ASD), outlining the prominently researched methods of treatment that have led to successful therapy for the ones being treated. Within this thesis, the definition of successful treatment of autistic individuals will be defined by how well the

The purpose of this thesis is to analyze in-depth the current research on Autism Spectrum Disorder (ASD), outlining the prominently researched methods of treatment that have led to successful therapy for the ones being treated. Within this thesis, the definition of successful treatment of autistic individuals will be defined by how well the individuals can adapt to their employment opportunities and their own social lives. Success will be measured through the effectiveness of specific treatments, such as speech therapy and therapeutic-based diets, to better gauge the success rate of treatment for autistic individuals. The thesis itself will serve as a review of the currently proposed treatment methods, analyzing where the most successful treatments were derived from and then offering a summary conclusion on the overall scope of the research. Recommendations on future research will be made to encapsulate all the research provided through which a scholarly lens was applied. Overall, the best methods of treatment will involve both a dietary and occupational approach, so as to tackle any environmental or genetic origins of ASD. More specifically, through a combination of vitamin and mineral supplements to manage behavioral symptoms combined with Applied Behavioral Analysis techniques, ASD can be more effectively treated to improve an individual’s quality of life.
ContributorsEnriquez, Elias (Author) / Adams, James (Thesis director) / Martin, Thomas (Committee member) / Barrett, The Honors College (Contributor) / School of Politics and Global Studies (Contributor) / Dean, W.P. Carey School of Business (Contributor)
Created2024-05
192727-Thumbnail Image.png
Description
Pitt-Hopkins Syndrome is not a well-known disorder, and there are not many treatments dedicated to alleviating the severe symptoms that children and adults with Pitt-Hopkins Syndrome suffer through. The purpose of this study is to create questionnaires tailored to Pitt-Hopkins syndrome. With the dearth of Pitt-Hopkins Syndrome research, more knowledge

Pitt-Hopkins Syndrome is not a well-known disorder, and there are not many treatments dedicated to alleviating the severe symptoms that children and adults with Pitt-Hopkins Syndrome suffer through. The purpose of this study is to create questionnaires tailored to Pitt-Hopkins syndrome. With the dearth of Pitt-Hopkins Syndrome research, more knowledge on the disorder and treatments to aid in daily functioning and quality of life can be attained through specialized symptom tracking questionnaires. During this study, the research team designed and finalized two Pitt-Hopkins Syndrome symptom specific questionnaires. Some of the most notable results included the discovery of the most severe symptoms: verbal expression, cognition, social activity, and attention. Additionally, through cross-correlational analysis interrelated symptom clusters that can be targeted for treatment have been discovered.
ContributorsWatkins, Cierra (Author) / Garcia, Kristin (Co-author) / Adams, James (Thesis director) / Kirby, Jasmine (Committee member) / Barrett, The Honors College (Contributor) / School of Life Sciences (Contributor)
Created2024-05
157441-Thumbnail Image.png
Description
Organic electronics have remained a research topic of great interest over the past few decades, with organic light emitting diodes (OLEDs) emerging as a disruptive technology for lighting and display applications. While OLED performance has improved significantly over the past decade, key issues remain unsolved such as the development of

Organic electronics have remained a research topic of great interest over the past few decades, with organic light emitting diodes (OLEDs) emerging as a disruptive technology for lighting and display applications. While OLED performance has improved significantly over the past decade, key issues remain unsolved such as the development of stable and efficient blue devices. In order to further the development of OLEDs and increase their commercial potential, innovative device architectures, novel emissive materials and high-energy hosts are designed and reported.

OLEDs employing step-wide graded-doped emissive layers were designed to improve charge balance and center the exciton formation zone leading to improved device performance. A red OLED with a peak efficiency of 16.9% and an estimated LT97 over 2,000 hours at 1,000 cd/m2 was achieved. Employing a similar structure, a sky-blue OLED was demonstrated with a peak efficiency of 17.4% and estimated LT70 over 1,300 hours at 1,000 cd/m2. Furthermore, the sky-blue OLEDs color was improved to CIE coordinates of (0.15, 0.25) while maintaining an efficiency of 16.9% and estimated LT70 over 600 hours by incorporating a fluorescent sensitizer. These devices represent literature records at the time of publication for efficient and stable platinum phosphorescent OLEDs.

A newly developed class of emitters, metal-assisted delayed-fluorescence (MADF), are demonstrated to achieve higher-energy emission from a relatively low triplet energy. A green MADF device reaches a peak efficiency of 22% with an estimated LT95 over 350 hours at 1,000 cd/m2. Additionally, a blue charge confined OLED of PtON1a-tBu demonstrated a peak efficiency above 20%, CIE coordinated of (0.16, 0.27), and emission onset at 425 nm.

High triplet energy hosts are required for the realization of stable and efficient deep blue emission. A rigid “M”-type carbazole/fluorene hybrid called mDCzPF and a carbazole/9-silafluorene hybrid called mDCzPSiF are demonstrated to have high triplet energies ET=2.88 eV and 3.03 eV respectively. Both hosts are demonstrated to have reasonable stability and can serve as a template for future material design. The techniques presented here demonstrate alternative approaches for improving the performance of OLED devices and help to bring this technology closer to widespread commercialization.
ContributorsKlimes, Kody George (Author) / Li, Jian (Thesis advisor) / Adams, James (Committee member) / Wang, Liping (Committee member) / Arizona State University (Publisher)
Created2019
154499-Thumbnail Image.png
Description
White organic light emitting diodes (WOLEDs) are currently being developed as the next generation of solid state lighting sources. Although, there has been considerable improvements in device efficiency from the early days up until now, there are still major drawbacks for the implementation of WOLEDs to commercial markets. These drawbacks

White organic light emitting diodes (WOLEDs) are currently being developed as the next generation of solid state lighting sources. Although, there has been considerable improvements in device efficiency from the early days up until now, there are still major drawbacks for the implementation of WOLEDs to commercial markets. These drawbacks include short lifetimes associated with highly efficient and easier to fabricate device structures. Platinum (II) complexes are been explored as emitters for single emissive layer WOLEDs, due to their higher efficiencies and stability in device configurations. These properties have been attributed to their square planar nature. Tetradentate platinum (II) complexes in particular have been shown to be more rigid and thus more stable than their other multidentate counterparts. This thesis aims to explore the different pathways via molecular design of tetradentate platinum II complexes and in particular the percipient engineering of a highly efficient and stable device structure. Previous works have been able to obtain either highly efficient devices or stable devices in different device configurations. In this work, we demonstrate a device structure employing Pt2O2 as the emitter using mCBP as a host with EQE of above 20% and lifetime values (LT80) exceeding 6000hours at practical luminance of 100cd/m2. These results open up the pathway towards the commercialization of white organic light emitting diodes as a solid state lighting source.
ContributorsOloye, Temidayo Abiola (Author) / Li, Jian (Thesis advisor) / Alford, Terry (Committee member) / Adams, James (Committee member) / Arizona State University (Publisher)
Created2016